NEW YORK (GenomeWeb News) - The National Institutes of Health extended the submission date for its Commercialization Assistance Program to Aug. 7.
The NIH SBIR CAP connects SBIR Phase II awardees with partners and investors to help move the products into the marketplace. The program is appropriate for researchers with clinical products looking for investments or alliances.
STTR awardees are not eligible to participate at this time.
The program is limited to approximately 125 awardees.
A description of the program can be found here.